GHB acts at two receptor websites inside the brain, the GABAB and certain GHB receptors. Action at both of these receptor web sites results in the CNS depressant, stimulant and psychomotor impairment consequences of GHB. A more recent artificial drug, SCH-50911, which acts like a selective GABAB antagonist, rapidly reverses https://cruzeytpc.anchor-blog.com/16141771/considerations-to-know-about-ghb-pill